Todd Talarico

Biography

Dr. Talarico was responsible for overseeing the design-build project which resulted in the North Carolina Medicago production facility. Todd directed the technical transfer and production of 10 million pandemic influenza doses in 30 days once the facility construction was completed. In addition, he has been responsible for ensuring that new products such as the anti-Ebola mAb are developed and produced at Medicago. Previously, Todd spent over eight years as Senior Director of Development for AlphaVax, where he was responsible for scale-up and purification processes to support manufacturing operations, including characterization activities for virus and process intermediates. Prior to AlphaVax, he was Director of Product Development for Apex Bioscience. He received his PhD in Microbiology from North Carolina State University and holds a BSc in Chemical Engineering from Penn State. Dr. Talarico was responsible for overseeing the design-build project which resulted in the North Carolina Medicago production facility. Todd directed the technical transfer and production of 10 million pandemic influenza doses in 30 days once the facility construction was completed. In addition, he has been responsible for ensuring that new products such as the anti-Ebola mAb are developed and produced at Medicago. Previously, Todd spent over eight years as Senior Director of Development for AlphaVax, where he was responsible for scale-up and purification processes to support manufacturing operations, including characterization activities for virus and process intermediates. Prior to AlphaVax, he was Director of Product Development for Apex Bioscience. He received his PhD in Microbiology from North Carolina State University and holds a BSc in Chemical Engineering from Penn State.

Research Interest

Clinical Pharmacy  Pharmaceutical Administration Medicinal Chemistry